Fadogia Agrestis: Why I’m Cautious About the Supplement Huberman Made Famous

Quick Review: Fadogia Agrestis

Not a blanket no, but a cautious conditional. Fadogia appears to stimulate LH and raise testosterone in animal models, and some human self-reports are consistent with that mechanism. The problem is the animal toxicity data at high doses – testicular toxicity at extended high doses in rodent studies – and a near-complete absence of human safety trials. If you’re going to use it, the protocol matters more than the ingredient itself: low dose, strict cycling, and not stacking it with other LH-stimulant compounds.

• Best for: Men who have exhausted the foundation stack, have total T in the lower-normal range, want to try LH stimulation before considering clinical options, and are willing to cycle carefully
• Dosage I use with clients (when I do): 400-600mg daily, not exceeding 600mg, from a verified extract source
• Cycling protocol: 8 weeks on, 4 weeks off – non-negotiable given the animal data
• Would I recommend it: Conditional – only after foundation stack is optimized, only with cycling, not for men who already have healthy T levels

Andrew Huberman mentioned fadogia agrestis on his podcast, and since then my inbox has been a different place. I get questions about it every week. I’ve seen clients who had already been taking it for six months before we connected. I’ve heard it described as “the thing that actually works” by men who haven’t run bloodwork in a year and are extrapolating from how they feel.

I’m going to give you my honest read on it, which is more nuanced than either the fans or the skeptics usually present. I’m going to mention Huberman once more in this article and then move on, because the supplement deserves to be evaluated on its own merits rather than filtered through the reputation of whoever introduced it to the mainstream.

Fadogia agrestis is a West African plant. The primary mechanism appears to be stimulation of (luteinizing hormone, the pituitary signal that tells the Leydig cells in the testes to produce testosterone). Animal models – specifically rodent studies – have shown meaningful T increases through this pathway. The LH-stimulation mechanism is real and well-documented in preclinical research.

The concern is also documented in that same preclinical research: testicular toxicity at high doses in extended rodent trials. Dose-dependent histological changes in testicular tissue. This is not a rumor or speculation. It’s in the literature. The question that has not been answered, because the human trials haven’t been done, is whether these effects translate to humans at the doses people are actually taking, and whether they occur at lower doses with the cycling protocols that users typically follow.

I don’t know the answer. Neither does anyone else, including the people selling it.

What Cameron Falk showed me

Cameron Falk is 25, junior engineer in Phoenix, had been lifting for four years when he came to me. His T was 520, free T on the lower end, and he’d already been taking fadogia at 600mg daily for about two months before our first conversation. He’d noticed what he described as an increase in “drive and aggression” in the gym, and subjectively felt his recovery was better. He hadn’t run bloodwork during that period.

We ran a panel. His total T had moved to 680, which was genuinely meaningful from his baseline. LH was elevated at 8.2 mIU/mL – consistent with the LH-stimulation mechanism actually functioning. His testicular volume on clinical assessment was normal. No obvious red flags at eight weeks of use at 600mg.

But here’s my concern with Cameron’s case: he was 25, which means his hypothalamic-pituitary-testicular axis was already functioning well. His T at 520 wasn’t suppressed by any obvious mechanism. He had room to push production higher through LH stimulation, and the fadogia appeared to do that. The question I asked him was whether he needed an LH-stimulant at 25, or whether his energy and training improvements were coming from something else in his protocol we hadn’t isolated.

I told him to cycle off for four weeks and run another panel. His T came back to 560 at the end of the off-cycle, settling higher than his original baseline – which is consistent with the LH-stimulation having produced a sustained response rather than a purely transient one. I put him back on at 400mg rather than 600mg, with a strict 8-weeks-on, 4-weeks-off schedule. He’s been running that protocol for eight months now without concerning bloodwork changes.

This is not a success story for fadogia. It’s an “hasn’t gone wrong yet at responsible doses with monitoring” story. That’s a different thing.

The animal toxicity data and what it means

I’m not going to overstate the rodent findings. Rat and human physiology differ meaningfully, and toxicity observed at very high doses in rodents doesn’t automatically translate to human harm at lower doses. This applies to many substances that are perfectly safe in humans at appropriate doses.

What I won’t do is ignore the data. The testicular toxicity observed in some rodent studies was dose-dependent – it was worse at higher doses and appeared to be less severe or absent at lower doses. The cycling protocols that experienced users follow – 8 weeks on, 4 weeks off at minimum – are designed to give testicular tissue recovery time. This is a reasonable precaution given the mechanistic concern, not an overreaction.

The honest answer is that we don’t have the human safety data to know where the risk threshold is, if one exists at commonly used doses. Joey Savage, in a formulator conversation I found useful, put it directly: “For fadogia, there’s mostly only rodent studies and there are some negative side effects with fadogia if taken for a long period of time on testicular health.” He went on to acknowledge that it does increase testosterone in those models – the mechanism isn’t questioned. The duration and dose safety in humans is.

That uncertainty should be part of your decision. If you’re 28 with T at 550 and good overall health, the risk-benefit calculation looks different than if you’re 44 with T at 320 and you’ve already optimized lifestyle, foundation supplements, and are weighing this against clinical options. For the 44-year-old in the second scenario, a carefully monitored cycle of fadogia may be a reasonable thing to try before committing to TRT. For the 28-year-old in the first scenario, I’m not sure what problem we’re solving that justifies the uncertainty.

Sam’s non-response

Sam Reichert wanted to try fadogia after his foundation stack had been running successfully for several months. His T was at 640, SHBG reasonable, free T in a good place. He was curious about it the way he’s curious about everything – he wanted to understand whether the mechanism worked for him specifically.

He ran eight weeks at 500mg. His bloodwork at the end of the cycle showed LH at 6.8 – slightly elevated from his previous baseline of 5.2 – and total T at 670. A modest increase. His subjective experience was minimal – he said he “felt nothing different.” He concluded it wasn’t a significant responder case for him at this dose and with his T already in a better range.

This matches what I’d expect. Fadogia’s LH-stimulation mechanism works best when there’s room for LH to drive more production – when total T has meaningful runway below the setpoint. When T is already in the 600s and reasonably optimized, pushing LH harder doesn’t produce dramatic changes because the system is already working well. The population where fadogia does the most is lower-normal T with functional but underperforming HPTA signaling.

If you’re going to use it

This is the practical section, which I’ll keep honest about the limits of what we know.

Get bloodwork before you start. Total T, free T, LH, FSH, and ideally a baseline testicular ultrasound if you want to be thorough about monitoring. Run it at 400-600mg from a brand that provides a Certificate of Analysis and uses genuine fadogia agrestis extract – not a crude powder with unknown standardization. Monitor LH as a proxy for whether the mechanism is functioning: if your LH rises meaningfully during a cycle, the supplement is doing what it’s supposed to do. If LH is flat, it either isn’t working or your signaling pathway isn’t the right target.

Cycle strictly. Eight weeks on, four weeks off. I would not run fadogia continuously under any circumstances given the current evidence profile. The cycling isn’t optional – it’s the risk mitigation strategy that makes the protocol defensible given what we don’t know.

Don’t stack it with other LH-stimulant compounds simultaneously. Tongkat ali works through overlapping mechanisms. Running both at full dose simultaneously is compounding the hormonal signaling intervention in a way that compounds the uncertainty. I’ve seen clients do this and report strong effects – but “strong effects” in the direction of pushing LH and T higher also means potentially stronger effects in whatever risk direction exists. One LH-stimulant at a time.

The natural T optimization work I do through Anabolic Alchemy doesn’t include fadogia as a primary protocol component for most clients precisely because the foundation stack and training optimization produce meaningful results without the uncertainty profile that comes with this ingredient. For the subset of clients who’ve maxed out the first-tier interventions and are specifically looking at LH stimulation, it’s a conversation we have with appropriate context. It’s not a place I start.

The supplement is real. The mechanism is real. The unknowns are also real. Make your decision with all three in view, not just the first two.